Uricosuric and nephroprotective properties of Ramulus Mori ethanol extract in hyperuricemic mice

Journal of Ethnopharmacology

Volumn 143, Issue 3, 2012, Pages 896-904

  Shi, Yun Wei ^a   Wang, Cai Ping ^a   Wang, Xing ^a   Zhang, Yuan Li ^a   Liu, Lei ^a   Wang, Ru Wei ^b   Ye, Jian Feng ^b   Hu, Lin Shui ^c   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

^b Zhejiang Institute of Traditional Chinese Medicine and Natural Drug   (China)

^c Zhejiang Conba Pharmaceutical Co LTD   (China)

Author keywords

Hyperuricemia; Nephroprotection; Organic ion transporters; Ramulus Mori; Uricosuric effect

Indexed keywords

7 HYDROXYCUMARIN; BUTEIN; CARRIER PROTEIN; CREATININE; GLUCOSE TRANSPORTER 9; HYPERIN; ISOQUERCETIN; KAEMPFEROL; MESSENGER RNA; MORIN; MULBERROSIDE A; MULBERRY EXTRACT; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; OTERACIL POTASSIUM; OXYRESVERATROL; PARA COUMARIC ACID; QUERCETIN; RESVERATROL; RUTOSIDE; UNCLASSIFIED DRUG; URATE; URATE TRANSPORTER 1; URIC ACID; URICOSURIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERURICEMIA; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ANIMALS; BLOOD UREA NITROGEN; CREATININE; ETHANOL; HYPERURICEMIA; KIDNEY; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MORUS; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; SOLVENTS; URIC ACID;

MORUS ALBA; MUS;

EID: 84866736403     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.08.023     Document Type: Article

References (30)

1. T. Bardin Current management of gout in patients unresponsive or allergic to allopurinol Joint Bone Spine 71 2004 481 485
2. L.H. Beck, J.T. Harrington, J.P. Kassirer, R. Perrone, N.E. Madias, J. Strom, P. Kurtin, and V. Canzanello Requiem for Gouty Nephropathy Kidney International 30 1986 280 287
3. H.K. Choi, D.B. Mount, and A.M. Reginato Pathogenesis of gout Annals of Internal Medicine 143 2005 499 516
4. K.O. Chung, B.Y. Kim, M.H. Lee, Y.R. Kim, H.Y. Chung, J.H. Park, and J.O. Moon In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L Journal of Pharmacy and Pharmacology 55 2003 1695 1700
5. C.A. de la Lastra, and I. Villegas Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications Molecular Nutrition & Food Research 49 2005 405 430
6. A. Enomoto, and H. Endou Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease Clinical and Experimental Nephrology 9 2005 195 205
7. A. Enomoto, H. Kimura, A. Chairoungdua, Y. Shigeta, P. Jutabha, S.H. Cha, M. Hosoyamada, M. Takeda, T. Sekine, T. Igarashi, H. Matsuo, Y. Kikuchi, T. Oda, K. Ichida, T. Hosoya, K. Shimokata, T. Niwa, Y. Kanai, and H. Endou Molecular identification of a renal urate-anion exchanger that regulates blood urate levels Nature 417 2002 447 452
8. S. Erazo, R. Garcia, N. Backhouse, I. Lemus, C. Delporte, and C. Andrade Phytochemical and biological study of Radal Lomatia hirsuta (Proteaceae) Journal of Ethnopharmacology 57 1997 81 83
9. D.I. Feig, B. Rodriguez-Iturbe, T. Nakagawa, and R.J. Johnson Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension Hypertension 48 2006 25 26
10. V. Garcia-Mediavilla, I. Crespo, P.S. Collado, A. Esteller, S. Sanchez-Campos, M.J. Tunon, and J. Gonzalez-Gallego The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells European Journal of Pharmacology 557 2007 221 229
11. N. Glube, E. Closs, and P. Langguth OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1) Molecular Pharmaceutics 4 2007 160 168
12. B. Grover, D. Buckley, A.R. Buckley, and W. Cacini Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes Journal of Pharmacology and Experimental Therapeutics 308 2004 949 956
13. Y. Habu, I. Yano, A. Takeuchi, H. Saito, M. Okuda, A. Fukatsu, and K. Inui Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1 rOAT3 and rOCT2 Biochemical Pharmacology 66 2003 1107 1114
14. M.D. Harris, L.B. Siegel, and J.A. Alloway Gout and hyperuricemia American Family Physician 59 1999 925 934
15. M. Hosoyamada, K. Ichida, A. Enomoto, T. Hosoya, and H. Endou Function and localization of urate transporter 1 in mouse kidney Journal of the American Society of Nephrology 15 2004 261 268
16. Q.H. Hu, R.Q. Jiao, X. Wang, Y.Z. Lv, and L.D. Kong Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice Journal of Ethnopharmacology 128 2010 685 692
17. N.Z. Jiang, M. Bo, Z.P. Wu, and J.Z. Tan A review on the chemical constituents and pharmacological activity studies of Ramulus Mori Jiangsu Sericulture 28 2006 4 7
18. S. Lee, S.H. Jung, Y.S. Lee, M. Yamada, B.K. Kim, K. Ohuchi, and K.H. Shin Antiinflammatory activity of hyperin from Acanthopanax chiisanensis roots Archives of Pharmacal Research 27 2004 628 632
19. Y.Q. Li, F.C. Zhou, F. Gao, J.S. Bian, and F. Shan Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase Journal of Agricultural and Food Chemistry 57 2009 11463 11468
20. H. Matsuo, T. Chiba, S. Nagamori, A. Nakayama, H. Domoto, K. Phetdee, P. Wiriyasermkul, Y. Kikuchi, T. Oda, J. Nishiyama, T. Nakamura, Y. Morimoto, K. Kamakura, Y. Sakurai, S. Nonoyama, Y. Kanai, and N. Shinomiya Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia American Journal of Human Genetics 83 2008 744 751
21. M.K. Pandey, S.K. Sandur, B. Sung, G. Sethi, A.B. Kunnumakkara, and B.B. Aggarwal Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappa B and NF-kappa B-regulated gene expression through direct inhibition of I kappa B alpha kinase beta on cysteine 179 residue Journal of Biological Chemistry 282 2007 17340 17350
22. F. Preitner, O. Bonny, A. Laverriere, S. Rotman, D. Firsov, A. Da Costa, S. Metref, and B. Thorens Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy Proceedings of the National Academy of Sciences of the United States of America 106 2009 15501 15506
23. A.N. Rizwan, and G. Burckhardt Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles Pharmaceutical Research 24 2007 450 470
24. Y. Sakurai, H. Motohashi, H. Ueo, S. Masuda, H. Saito, M. Okuda, N. Mori, M. Matsuura, T. Doi, A. Fukatsu, O. Ogawa, and K. Inui Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases Pharmaceutical Research 21 2004 61 67
25. R. Schneider, C. Sauvant, B. Betz, M. Otremba, D. Fischer, H. Holzinger, C. Wanner, J. Galle, and M. Gekle Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats American Journal of Physiology-Renal Physiology 292 2007 F1599 F1605
26. S. Tokuhiro, R. Yamada, X.T. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, H. Furukawa, M. Nagashima, S. Yoshino, A. Mabuchi, A. Sekine, S. Saito, A. Takahashi, T. Tsunoda, Y. Nakamura, and K. Yamamoto An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis Nature Genetics 35 2003 341 348
27. V. Vitart, I. Rudan, C. Hayward, N.K. Gray, J. Floyd, C.N. Palmer, S.A. Knott, I. Kolcic, O. Polasek, J. Graessler, J.F. Wilson, A. Marinaki, P.L. Riches, X. Shu, B. Janicijevic, N. Smolej-Narancic, B. Gorgoni, J. Morgan, S. Campbell, Z. Biloglav, L. Barac-Lauc, M. Pericic, I.M. Klaric, L. Zgaga, T. Skaric-Juric, S.H. Wild, W.A. Richardson, P. Hohenstein, C.H. Kimber, A. Tenesa, L.A. Donnelly, L.D. Fairbanks, M. Aringer, P.M. McKeigue, S.H. Ralston, A.D. Morris, P. Rudan, N.D. Hastie, H. Campbell, and A.F. Wright SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout Nature Genetics 40 2008 437 442
28. C.P. Wang, X. Wang, X. Zhang, Y.W. Shi, L. Liu, and L.D. Kong Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice Journal of Pharmacy & Pharmaceutical Sciences 13 2010 411 427
29. C.P. Wang, Y.M. Wang, X. Wang, X. Zhang, J.F. Ye, L.S. Hu, and L.D. Kong Mulberroside A possesses potent uricosuric and nephroprotective effects in hyperuricemic mice Planta Medica 77 2011 786 794
30. J.X. Zhu, Y. Wang, L.D. Kong, C. Yang, and X. Zhang Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver Journal of Ethnopharmacology 93 2004 133 140